Find trending articles through Social News Discovery®! Providing a collaboration of news through social media technologies.
Follow your friends and create your own Online Social Newspaper! Invite your friends to follow you from Facebook. Filter the news articles you see by section, clipper, or mood. Rate each article and comment on all news clips!
Receive site and email notifications about comments and news clips that you are collaborating on!
Get the latest news on the Everyone page, the viral and trending news clips will always be at the top! See the trending news and articles!
"J&J drug patent out, cheaper version looms- TRENTON, N.J. — A cheaper version of Johnson & Johnson’s top-selling drug, the pricey rheumatoid arthritis treatment Remicade, could be available in the U.S. two years early after a federal judge ruled that a key patent on the drug is invalid.J&J,...", www.chicagolawbulletin.com
"TRENTON, N.J. (AP) - A cheaper version of Johnson & Johnson's top-selling drug, the pricey rheumatoid arthritis treatment Remicade, could be available in the U.S. two years early after a federal judge ruled that a key patent on the drug is invalid. - LINDA A. JOHNSON, Philadelphia AP", www.philly.com
"The US District Court for the District of Massachusetts on Thursday officially ruled Janssen’s main formulation patent on its blockbuster rheumatoid arthritis drug Remicade invalid, making way for the entry of biosimilars to the US market.The ruling brightens the prospect for South Korean biosimilars developer Celltrion and its regional sales partner Pfizer’s plans to debut Remsima, a biosimilar drug referencing Re...", www.koreaherald.com
"The US District Court for the District of Massachusetts ruled Janssen’s Remicade patent invalid on Aug. 17. This repeats the decision of the US Patent & Trademark Office from February 2015, and brightens the prospect of Celltrion(chairman Seo Jung-jin) and Pfizer’s plan to introduce a biosimilar version of the rheumatoid arthritis and autoimmune disease treatment in the US within this year. Janssen Biotech filed...", www.koreaherald.com
Please enjoy the site during our beta phase and provide us with feedback on suggestions and issue details. Please remember that we are still in beta and there will be issues and site changes during this time.
Newsclip® the leading Online Social Newspaper, find trending articles through Social News Discovery®!
You can reopen the "Getting Started Tutorial" dialog from within the About menu in the top right corner.